Coronary vasodilators: pharmacological aspect
Bazaugour, R.; Evreux, J.C.; Evrard, J.P.
Lyon Medical 228(17): 427-433
1972
ISSN/ISBN: 0024-7790 PMID: 4658523 Document Number: 51007
Document emailed within 1 workday
Related Documents
Chan, K.Y.; Yip, W.C.; Tay, J.S. 1988: Cardiovascular pharmacological therapy in children--a review. Part 2: Vasodilators and diuretics Journal of the Singapore Paediatric Society 30(3-4): 100-108Nakane, T.; Chiba, S. 1988: Comparative study of direct coronary vascular responses to diltiazem, adrenergic beta-blockers and other vasodilators in isolated, perfused dog and monkey coronary arteries Archives Internationales de Pharmacodynamie et de Therapie 291: 153-162
Fuder, H. 1993: Is the use of short-acting anesthetics for long-term sedation meaningful? the pharmacological aspect Klinische Anasthesiologie und Intensivtherapie 44: 117-124
Langnickel, R.; Bluth, R. 1985: Pharmacokinetic properties and indications for modern vasodilators. 1. Pharmacodynamic properties of vasodilators Zeitschrift für Arztliche Fortbildung 79(19): 821-825
Fujii, T.; Matsuzaki, M. 1998: The aspect and pathophysiology of acute coronary syndromes Nihon Rinsho. Japanese Journal of Clinical Medicine 56(10): 2465-2470
Di Mario, C.; Strikwerda, S.; Gil, R.; Azar, A.; Rames, A.; Serruys, P.W. 2000: Long-term changes in the response of conductance and resistance coronary vessels to endothelium-dependent and independent vasodilators. A double-blind placebo-controlled study of the effect of a 6-month treatment with cilazapril Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 1(10): 674-683
Zdichynec, B. 1971: Localization of infarction changes on the electrocardiogram and type of coronary algia from the aspect of diabetes and hypertension Casopis Lekaru Ceskych 110(33): 751-754
Puech, C.; Hoppeler, J.M. 1984: Stérilisation volontaire chez la femme: aspect médico-légal - Voluntary sterilization in womer: forensic aspect Concours Medical (Paris) 106(36): 3461-3465
Spławińska, B.; Spławiński, J. 1987: Pharmacological prevention of coronary thrombosis Polski Tygodnik Lekarski 42(26): 795-801
Brzostek, T. 2003: Pharmacological treatment in patients undergoing coronary angioplasty Kardiologia Polska 59(11): 457-460
Duckles, S.P. 1988: Vascular muscarinic receptors: pharmacological characterization in the bovine coronary artery Journal of Pharmacology and Experimental Therapeutics 246(3): 929-934
Kuzner, J.; Drevensek, G.; Gersak, B.; Budihna, M. 2004: Hypoxic and pharmacological preconditioning preserves vasomotor response of porcine coronary artery Polish Journal of Pharmacology 56(6): 789-797
Senda, S.; Masugata, H. 1997: Assessment of coronary artery lesions and myocardial viability by pharmacological stress echocardiography Nihon Rinsho. Japanese Journal of Clinical Medicine 55(Suppl 1): 615-618
Kowalski, J.; Pawlicki, L.; Kośmider, M.; Skłodowska, M.; Gromadzińska, J.; Kedziora, J.; Luciak, M.; Błaszczyk, J. 1995: The effect of coronary angioplasty on superoxide anion generation and lipid peroxidation. Propriety of pharmacological intervention Polish Journal of Pharmacology 47(2): 163-168
Hézard, N.; Metz, D.; Garnotel, R.; Droullé, C.; Potron, G.; Nguyen, P. 2000: Platelet-leukocyte interactions in coronary heart disease: pathophysiology, clinical relevance, pharmacological modulation Journal des Maladies Vasculaires 25(5): 343-348
Baribwira, C.; Muteganya, D.; Ndihokubwayo, J.B.; Moreno, J.L.; Nduwimana, M.; Rufyikiri, T. 1994: Un aspect des maladies sexuellement transmissibles chez le jeune enfant au Burundi: les gonocoques secondaires à des sévices sexuels - An aspect of sexually transmitted diseases in infants in Burundi:Gonorrhea due to sexuel abuse Medecine Tropicale 54(3): 231-233
Feder, G.; Griffiths, C. 1998: Managing established coronary heart disease. Practice teams need support in organising pharmacological and lifestyle interventions Bmj 316(7127): 309
Kocemba, J.; Kawecka-Jaszcz, K.; Magdoń, M. 1981: The effect of six years lasting primary non pharmacological prevention of coronary heart disease on hypercholesterolemia in occupationally working men Przeglad Lekarski 38(12): 857-860
Jackson, C.V.; Crowe, V.G.; Frank, J.D.; Wilson, H.C.; Coffman, W.J.; Utterback, B.G.; Jakubowski, J.A.; Smith, G.F. 1992: Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis Journal of Pharmacology and Experimental Therapeutics 261(2): 546-552
Zsotér, T.T. 1983: Vasodilators Canadian Medical Association Journal 129(5): 424-428; 432